FDA Inspection 796961 — Abbott Laboratories

Abbott Laboratories — FEI 1451914

The FDA completed an inspection of Abbott Laboratories on Aug 24, 2012 in North Chicago, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 24, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Project Evaluation: Devices
Location
North Chicago, IL (United States)

Additional Details

Postmarket Audit Inspections

Citations

IDCFRDescription
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
312821 CFR 820.90(a)Nonconforming product control
313021 CFR 820.100(a)Lack of or inadequate procedures
317321 CFR 820.198(d)Evaluation, timeliness, identification
326221 CFR 820.250(a)Statistical techniques - Lack of or inadequate procedures
342721 CFR 820.50(a)(2)Supplier oversight
73221 CFR 803.50(a)(2)Individual Report of Malfunction

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.